NSE : ERIS
938.85
-6.1(-0.65%)
IntradaySell
947.95
30-Nov 09:45
63.71
53.04
52.02
Up
Up
Up
48
91
42
LTP938.85%Chg-0.65
Change-6.1Earning28.31
Open951.9552 WH971.9
High952.0552 WL551.3
Low928.7Vol125228
Pr.Close944.95Mkt cap127.71
P/E32.93Beta0
Av. VolumeATP(Aprox. )939.33
Last Vol168864.00Vol %66.32
5 DMA9699120 DMA162804.1
10 DMA99483.850 DMA188827.84
Rs 1 Month1.85Rs 6 Month5.67
Pivot PointLTP938.85
DailyPP935.133
S1918.217R1947.917
S2905.433R2964.833
S3888.517R3977.617
WeeklyPP932.85
S1903.5R1953.35
S2883R2982.7
S3853.65R31003.2
MonthlyPP863.917
S1799.883R1923.833
S2739.967R2987.867
S3675.933R31047.78
Sell BelowBuy Above
Intraday926.675Intraday941.525
Shot Term893.25Shot Term968.025
Long Term831.9Long Term893.875
Buy TargetSell Target
Intraday954.308Intraday909.758
Shot Term1042.8Shot Term872.75
Long Term955.85Long Term767.867
H,L,CHighLowClose
L Day952.05922.35931
L Week962.2912.35924
L Month927.95804859.8
L3 Months971.9792.35814
L6 Months971.9630.9643.5
Movining Av.(SMA)
Daily
5 DMA937.250 DMA876.862
10 DMA931.3989 DMA845.061
20 DMA909.325100 DMA830.136
30 DMA891.113150 DMA762.997
34 DMA891.151200 DMA724.953
Weekly
5 DMA897.7730 DMA777.677
10 DMA882.47534 DMA757.522
20 DMA840.02350 DMA715.078
Performance
T Chg(%)-0.65 %3 Months13.869 %
1 Week-0.755814 %6 Months46.9249 %
1 Month8.66319%9 month48.0953%
1 Year42.25 %YTD0.00843179 %

FAQ

What is the share price of Eris Lifesciences Ltd.?

Eris Lifesciences Ltd. share price is ₹938.85 As on 30 Nov, 2023 | 03:32PM.Company shares prices keep fluctuating as per market conditions. There may be many reasons to rise and fall of share price of stocks. It may be market conditions, it may be sector and industry reasons and it may be stocks itself like earnings, order, upgrade or downgrade etc.

What is the Market cap of Eris Lifesciences Ltd.?

The Market Cap of Eris Lifesciences Ltd. is ₹12771 Cr As on 30 Nov, 2023 | 03:32PM. Market capitalization, or market cap, is the total value of a company's shares of stock. It is one measurement of a company's size. A high market cap signifies that the company has a larger presence in the market. Larger companies may have less growth potential compares to start-up firms. Market capitalization refers to how much a company is worth as determined by the stock market. It is defined as the total market value of all outstanding shares. To calculate a company's market cap, multiply the number of outstanding shares by the current market value of one share.

What is the PE ratio of Eris Lifesciences Ltd.?

The P/E ratio of Eris Lifesciences Ltd. is 32.93 As on 30 Nov, 2023 | 03:32PM. Price to Earnings Ratio or Price to Earnings Multiple is the ratio of share price of a stock to its earnings per share (EPS). PE ratio is one of the most popular valuation metric of stocks. Typically, the average P/E ratio is around 20 to 25. In general, a high P/E suggests that investors are expecting higher earnings growth in the future compared to companies with a lower P/E. A low P/E can indicate either that a company may currently be undervalued or that the company growth has stagnant due to its matured stage.

What is the 52-week high and 52-week low of Eris Lifesciences Ltd.?

A 52 week high of Eris Lifesciences Ltd. is ₹971.9 while 52 week low is ₹551.3. A 52 week high, as the name suggests, is the highest price that the security/stock has traded over a 52 week period i.e. a year. Similarly 52 week low is the lowest price that stock has traded over a 52 week period. It is a technical indicator that is used to analyse the security's current price. The 52 week high and 52 week low are also used to predict future movements as well. 52 week is bullish signal and 52 week low is bearish signal.

What is Support price of Eris Lifesciences Ltd.?

First support of Eris Lifesciences Ltd. is ₹918.22
Second support of Eris Lifesciences Ltd. is ₹905.43
Third support of Eris Lifesciences Ltd. is ₹888.52
Traders use support to plan entry. Support is the level at which demand is strong enough to stop the stock from falling any further. Support is specific point on chart at which maximum buiying occurs.

What is Resistance price of Eris Lifesciences Ltd.?

First resistance of Eris Lifesciences Ltd. is ₹947.92
Second resistance of Eris Lifesciences Ltd. is ₹964.83
Third resistance of Eris Lifesciences Ltd. is ₹977.62
Traders use resistance to plan exit of trade. Resistance is the level at which selling is strong enough to stop the stock from moving up any further. Resistance is specific point on chart at which maximum selling occurs.

What is Eris Lifesciences Ltd. share price target 2023?

First target of Eris Lifesciences Ltd. is ₹923.83
Second target of Eris Lifesciences Ltd. is ₹987.87
Third target of Eris Lifesciences Ltd. is ₹1047.78

What is Eris Lifesciences Ltd. share price target 2025?

First target of Eris Lifesciences Ltd. is ₹1158.10
Second target of Eris Lifesciences Ltd. is ₹1298.71
Third target of Eris Lifesciences Ltd. is ₹1382.54

What is Eris Lifesciences Ltd. share price history?

DateOpenHighLowCloseVolume%Chg
2023-11-30951.95952.05922.35934.65168864-0.65
2023-11-29949.95951.35932.35944.95466320.54
2023-11-28933.3954920.35942921582
2023-11-24946950.75920.15926.357333-2.17
2023-11-23947.5962.2940946119968-0.02
2023-11-22931949.3927946.451065312.21
2023-11-21921.55935915926.7771231.41
2023-11-20941.4945.8912.35917102368-1.67
2023-11-17913.9938897.7933.11448033
2023-11-16903.8910.45893.25907.15790581.14

Historical share price of stock is needed to find the trend of stock, performance analysis of stock price. History of share price is also used to find the demand and supply by analyzing volume data if available.

What is the ROE (Return on Equity) of Eris Lifesciences Ltd.?

The ROE of Eris Lifesciences Ltd. is 18.51% . Return on equity (ROE) is the measure of a company's net income divided by its shareholders' equity. ROE is a gauge of a corporation's profitability and how efficiently it generates those profits. The higher the ROE, the better a company. A return on equity ratio of 15% to 20% is usually considered good. ROE is a gauge of a corporation's profitability and how efficiently it generates those profits.

What is the Earning per Share (EPS) of Eris Lifesciences Ltd.?

The EPS of Eris Lifesciences Ltd. is ₹28.31. Earnings per share (EPS) is a company's net profit divided by the number of common shares it has outstanding. EPS indicates how much money a company makes for each share of its stock. There's no fixed answer for what is a good EPS. When comparing companies, it's helpful to look closely at how EPS is trending and how it matches up to competitor earnings. Remember that a higher EPS can suggest growth and stock price increases.

What is the ROCE of Eris Lifesciences Ltd.?

The ROCE of Eris Lifesciences Ltd. is 14.53%. Return on capital employed is a financial ratio that measures a company's profitability in terms of all of its capital. ROCE is similar to return on invested capital. It's always a good idea to compare the ROCE of companies in the same industry. The higher the ROCE, the better it is. The ratio calculated as 20% is considered good, indicating the company is more profitable and has a stable financial position in the market.

What is the NPM (Net profit margin) of Eris Lifesciences Ltd.?

The NPM of Eris Lifesciences Ltd. is 22.53%. Net Profit Margin is a financial ratio used to calculate the percentage of profit a company produces from its total revenue. Net profit margin helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are under control.

What is EBITDA of Eris Lifesciences Ltd.?

The EBITDA of Eris Lifesciences Ltd. is 32.31%. EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is the alternate method of measuring profitability in net income. EBITDA is useful when comparing companies with different capital investment, debt, and tax profiles.This key profitability measure is one of the main measures of a company's financial health and ability to generate cash. It is one of the most widely used measures of a company's financial health and ability to generate cash.

What is Debt to Equity ratio (D/E Ratio) of Eris Lifesciences Ltd.?

The debt to equity ratio of Eris Lifesciences Ltd. is 39.48. The debt-to-equity ratio (D/E ratio) shows how much debt a company has compared to its assets. It is found by dividing a company's total debt by total shareholder equity. Generally, a good debt to equity ratio is around 1 to 1.5. However, the ideal debt to equity ratio will vary depending on the industry, as some industries use more debt financing than others. A higher D/E ratio means the company may have a harder time covering its liabilities. It will be very hard if the economic scenario worsens.